VALORIE COOK: Open Payments
NPI 1942801204 · CARO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$831 in 32 payments from 12 companies in 2025. Trend: 2023 $597 · 2024 $653 · 2025 $831
Food & beverage: $720Education: $111
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 5 | $156 |
| Teva Pharmaceuticals USA, Inc. | 2 | $127 |
| Supernus Pharmaceuticals, Inc. | 6 | $110 |
| ABBVIE INC. | 3 | $102 |
| Lundbeck LLC | 4 | $82 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $57 |
| Vanda Pharmaceuticals Inc. | 3 | $54 |
| Otsuka America Pharmaceutical, Inc. | 2 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $31 |
| Alkermes, Inc. | 1 | $30 |
Products named: SPRAVATO, REXULTI, Qelbree, VRAYLAR, TRINTELLIX, FANAPT, CAPLYTA, ARISTADA.
Industry payments across MI — which companies pay providers there.
